Community/Retail

Officials with the FDA have permitted marketing of the first device for use in reducing symptoms of opioid withdrawal.

At the American Heart Association's 2017 Scientific Sessions, Niteesh Kumar Choudhry, MD, PhD, Associate Professor at Harvard Medical School, presented the results of a study that evaluated a technology-enabled intervention conducted by pharmacists to help patients with chronic metabolic conditions adhere to their medications.

At the American Heart Association's 2017 Scientific Sessions, Niteesh Kumar Choudhry, MD, PhD, Associate Professor at Harvard Medical School, explained how pharmacists can use a behaviorally tailored method of patient interviewing to assess patients' adherence barriers.

Officials with the FDA have approved benralizumab (Fasenra, AstraZeneca) for the add-on maintenance treatment of patients with severe eosinophilic asthma aged 12 years and older.

Officials with the FDA have issued a public health advisory on kratom, warning consumers about the potential risks associated with its use.

In this clip, Dr. Whelton discusses the guideline's emphasis on a team-based approach to assessing and treating hypertension in patients.

The guidelines, developed by the American Heart Association and the American College of Cardiology, lower the starting point for high blood pressure.

Children and young adults with diabetes may have a 7-fold increased risk of sudden cardiac death than those without diabetes.

Rising health care expenditures within the United States has been a major focus of policy makers, business owners, and individuals for years.

When pharmacists promote behavioral changes, it encourages positive patterns that last a lifetime.

Having the necessary items will alleviate stress and help attendees have a successful conference.

The sensor that is used along with aripiprazole was first cleared for use by the FDA in 2012; however, the approval of the pill and the sensor together represents a first for the FDA.

President Trump has nominated Alex M. Azar II to be the next secretary of the United States Department of Health and Human Services.

Does this antihyperglycemic combination medication need to be added to a formulary?

In this clip, Eliot A. Brinton, MD, FAHA, FNLA, president of the Utah Lipid Center, discusses how the EMPA-REG trial is a huge step forward for health care providers being able to treat patients with type 2 diabetes with medications that also reduce cardiovascular risk.

FDA officials took 2 steps today that will extend and facilitate treatment options for patients with schizophrenia and other mental health conditions.

A low sodium-DASH diet combination lowers blood pressure (BP) in adults with hypertension, according to the results of preliminary research at the American Heart Association’s (AHA) Scientific Sessions 2017.

The human papillomavirus (HPV) vaccine can protect against more than cancer-causing types of HPV, according to a recently-published study in The Journal of Infectious Diseases.

"Gut microbiome" is becoming a buzzword in the health care community.

Here are simple ways to get the necessary nutrition and feel energized during a hectic shift.

A growing body of data show that type 2 diabetes is at least in part rooted in inflammation, said Edgar Engleman, MD, a professor of pathology and medicine at Stanford University.

Genome sequencing may be fundamental to eventually offering precision medicine to patients with rheumatoid disease, but it will only reveal part of the patient’s health story.

Officials with the FDA have approved an adjuvanted hepatitis B vaccine, recombinant [Heplisav-B, Dynavax] for the prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older.

Pharmacy Times and Specialty Pharmacy Times recently announced the launch of a new social media campaign to spread awareness about the work pharmacists do to improve their patients' lives.

Learn about the new products and expanded indications approved by the FDA in October 2017.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

How can pharmacists handle the common dilemma of customers who show up after the store has shut its doors for the day?